Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000728387-26-000004
Filing Date
2026-03-16
Accepted
2026-03-16 16:12:49
Documents
107
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K catx-20251231.htm   iXBRL 10-K 3478303
2 EX-10.13 catx-ex10_13.htm EX-10.13 201620
3 EX-10.14 catx-ex10_14.htm EX-10.14 204028
4 EX-21.1 catx-ex21_1.htm EX-21.1 4767
5 EX-23.1 catx-ex23_1.htm EX-23.1 3919
6 EX-31.1 catx-ex31_1.htm EX-31.1 16601
7 EX-31.2 catx-ex31_2.htm EX-31.2 16585
8 EX-32 catx-ex32.htm EX-32 15731
9 GRAPHIC img56159038_0.jpg GRAPHIC 206891
10 GRAPHIC img56159038_1.jpg GRAPHIC 150102
11 GRAPHIC img56159038_2.jpg GRAPHIC 157273
12 GRAPHIC img56159038_3.jpg GRAPHIC 237824
13 GRAPHIC img56159038_4.jpg GRAPHIC 144915
14 GRAPHIC img56159038_5.jpg GRAPHIC 129896
  Complete submission text file 0000728387-26-000004.txt   18092984

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT catx-20251231.xsd EX-101.SCH 2095500
111 EXTRACTED XBRL INSTANCE DOCUMENT catx-20251231_htm.xml XML 2822302
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33407 | Film No.: 26756828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)